Tucker Asset Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Tucker Asset Management’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	–	–	1001
2024 Q4	$0	Hold	1,000	–	–	﹤0.01%	1604
2024 Q3	$0	Hold	1,000	–	–	﹤0.01%	1714
2024 Q2	$1	Hold	1,000	–	–	﹤0.01%	1661
2024 Q1	$1	Hold	1,000	–	–	﹤0.01%	1643
2023 Q4	$1	Hold	1,000	–	–	﹤0.01%	1461
2023 Q3	$0	Hold	1,000	–	–	﹤0.01%	1592
2023 Q2	$30	Hold	1,000	–	–	﹤0.01%	1138
2023 Q1	$18	Hold	1,000	–	–	﹤0.01%	1166
2022 Q4	$91	Hold	1,000	–	–	﹤0.01%	788
2022 Q3	$140	Hold	1,000	–	–	﹤0.01%	813
2022 Q2	$285	Hold	1,000	–	–	﹤0.01%	608
2022 Q1	$315	Buy	+1,000	New	+$1.07K	﹤0.01%	541

Tucker Asset Management's STAB Position: Q1 2025 in Review

Tucker Asset Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2025, closing a stake of 1,000 shares.

Tucker Asset Management first reported a position in STAB in Q1 2022 and held it in 12 quarters. The position peaked at $315 in Q1 2022. 0 funds tracked by Wall St. Rank hold STAB as of Q1 2025.

Tucker Asset Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Tucker Asset Management sold 1,000 Statera Biopharma, Inc. Common Stock shares in Q1 2025.
Tucker Asset Management first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2022 and held it in 12 quarters.
Tucker Asset Management's Statera Biopharma, Inc. Common Stock position peaked at $315 in Q1 2022.
0 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2025.

Based on Tucker Asset Management's 13F filing for Q1 2025, filed 6 Jan 2026.